Tyme Inc. - Investors - News Releases

Email Alerts

To opt-in for investor email alerts, please enter your email address in the field below and select at least one alert option. After submitting your request, you will receive an activation email to the requested email address. You must click the activation link in order to complete your subscription. You can sign up for additional alert options at any time.

At Tyme Inc., we promise to treat your data with respect and will not share your information with any third party. You can unsubscribe to any of the investor alerts you are subscribed to by visiting the ‘unsubscribe’ section below. If you experience any issues with this process, please contact us for further assistance.

By providing your email address below, you are providing consent to Tyme Inc. to send you the requested Investor Email Alert updates.

* Required

Email Address *

Mailing Lists *

Unsubscribe



Enter the code shown above.
*

17 State Street, 7th Floor
New York, NY 10004

1 Pluckemin Way, Suite 103
Bedminster, NJ 07921

[email protected]

Clinical Trial Inquiries

[email protected]

Powered By Q4 Inc. 5.23.3.1